Banner
Pilot Study: Fibromyalgia Fatigue Improved By TENS Therapy

Fibromyalgia is the term for a poorly-understood condition where people experience pain and fatigue...

High Meat Consumption Linked To Lower Dementia Risk

Older people who eat large amounts of meat have a lower risk of dementia and cognitive decline...

Long Before The Inca Colonized Peru, Natives Had A Thriving Trade Network

A new DNA analysis reveals that long before the Incan Empire took over Peru, animals were...

Mesolithic People Had Meals With More Tradition Than You Thought

The common imagery of prehistoric people is either rooting through dirt for grubs and picking berries...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll
The MUSE instrument on ESO's Very Large Telescope has given astronomers the best ever 3-D view of the deep Universe - in just 27 hours.

By taking very long exposure pictures of regions of the sky, astronomers have created many deep fields that have revealed much about the early Universe. The most famous of these was the original Hubble Deep Field, taken by the NASA/ESA Hubble Space Telescope over several days in late 1995. This spectacular and iconic picture rapidly transformed our understanding of the content of the Universe when it was young. It was followed two years later by a similar view in the southern sky -- the Hubble Deep Field South. 
A pre-clinical study of ANAVEX 2-73 found that it prevents mitochondrial dysfunction and blocks resulting oxidative stress and apoptosis (cell death) in a nontransgenic mouse model of Alzheimer's disease (AD).

Mitochondrial damages have been consistently reported as an early cause of Alzheimer's disease and appear before amyloid-beta plaques and memory decline in Alzheimer's patients and transgenic mice. If so, by preserving mitochondrial functionality and reducing other key Alzheimer's disease hallmarks, it has the potential to prevent, stop, slow or reverse the disease, in addition to treating its symptoms.
The use of animals in experimental research has soared at US laboratories, according to People for the Ethical Treatment of Animals (PETA), and taxpayer-funded scientists are the culprits.

The 25 largest recipients of government funding increased animal experimentation 73 percent in 15 years, despite growing public opposition to the practice and mounting evidence that animal studies often do not faithfully translate to people, they write.

They also say the data contradict government claims of reduced animal use and are at odds with government policies designed to curb and replace the use of animals in experiments. 

Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast cancer patients, including those whose disease has stopped responding to traditional endocrine treatments. Results of the phase II study, led by researchers in the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania , were published this month in Clinical Cancer Research. Earlier phase I results by researchers at Penn Medicine contributed to the development of palbociclib, which was recently approved by the U.S. Food and Drug Administration (FDA) for metastatic breast cancer patients just beginning to undergo endocrine therapy.

Case Western Reserve University dental researcher Pushpa Pandiyan has discovered a new way to model how infection-fighting T cells cause inflammation in mice.

The hope is that the discovery can lead to new therapies or drugs that jump-start weakened or poorly functioning immune systems, said Pandiyan, an assistant professor at Case Western Reserve School of Dental Medicine.

Pandiyan believes the process could lead to identifying and testing new drugs to replace antifungal medicines that have become ineffective as the fungi develop a resistance to them.

Pandiyan's findings are explained and demonstrated in the Journal of Visualized Experiments video and print article, "Th17 inflammation model of oropharyngeal candidiasis in immunodeficient mice."

Competition between doctors' offices, urgent care centers and retail medical clinics that cater to wealthy elites often leads to an increase in the number of antibiotic prescriptions written per person, finds a new analysis.

The number of physicians per capita and the number of clinics are significant drivers of antibiotic prescription rate, they found, with the highest per capita rates of antibiotic prescriptions found in the southeastern U.S. and along the West and East coasts. The team's comparative analysis of data for the years 2000 and 2010 were collected from the U.S. Census Bureau and the IMS Health Xponent database, which tracks prescriptions dispensed at the ZIP code level. Notably high rates were found in Manhattan, southern Miami and Encino.